Suchergebnisse - "Ravetch, Jeffrey V"

PubPharm (394)

41

MODULATING AGONISTIC TNFR ANTIBODIES

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | LI FUBIN

42

Fc-engineered antibody therapeutics with improved efficacy against COVID-19

enthalten in: Research square | 2021

von Yamin, R. | Jones, A. | Hoffmann, H. | +7

UpdateIn: Nature. 2021 Nov;599(7885):465-470. - PMID 34547765

43

Site-Selective Chemoenzymatic Modification on the Core Fucose of an Antibody Enhances Its Fcγ Receptor Affinity and ADCC Activity

enthalten in: Journal of the American Chemical Society | 2021

von Li, C. | Chong, G. | Zong, G. | +7

44

Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer

enthalten in: Science translational medicine | 2021

von Garris, C. | Wong, J. | Ravetch, J. | +1

CommentIn: J Urol. 2021 Dec;206(6):1511-1512. - PMID 34494456

45

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

46

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

47

Anti-inflammatory polypeptides

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | PINCETIC ANDREW

48

Anti-inflammatory polypeptides

enthalten in: Europäisches Patentamt | 2021

von RAVETCH JEFFREY V | PINCETIC ANDREW

49

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

enthalten in: The Journal of experimental medicine | 2021

von Schäfer, A. | Muecksch, F. | Lorenzi, J. | +15

UpdateOf: bioRxiv. 2020 Sep 15;:. - PMID 32995782

50

Four keys to unlock IgG

enthalten in: The Journal of experimental medicine | 2021

von Nimmerjahn, F. | Ravetch, J.